A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.

Clinical trial NCT07010107 · RECRUITING

Trial details

NCT number: NCT07010107
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Reflux Esophagitis (RE)

Start date: 2025-07-30
Primary completion: 2026-04-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.